Case Report Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/haematology.2.021

Isolated Kidney Infarct and Lupus Anticoagulant Positivity in a Young Patient with Mild SARS-CoV-2 Infection

  • 1Department of Internal Medicine, St Mary Mercy Hospital, Livonia, Michigan, USA
  • 2Department of Medicine, St Joseph Mercy Hospital, Ann Arbor, Michigan, USA
  • 3IHA Hospital Medicine, Michigan, USA
+ Affiliations - Affiliations

Corresponding Author

Jayesh Mittal, jayesh.mittal@stjoeshealth.org

Received Date: December 30, 2020

Accepted Date: January 18, 2021


Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2), known to cause Coronavirus disease 2019 (COVID-19), is a new strain of Coronavirus which was first reported in the Wuhan city of China in December 2019. COVID-19 has shown to increase the risk for thrombotic or thromboembolic events by altering the prothrombotic factor levels and direct endothelial cell invasion. Deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), and stroke have been more commonly reported, and incidence of these events is noted to be higher in patients with severe infection. Here we describe a case of a 38-year-old male with mild, self-limiting COVID-19 who developed an isolated renal infarction. He tested positive for Lupus Anticoagulant (LAC). The role of autoantibodies like LAC as a risk factor for thrombotic complications is a topic of debate and needs to be studied further. This uncommon case warrants identification of patients who might be at a higher risk for thrombotic events even with milder forms of COVID-19, and following and managing such patients closely.


Coronavirus/COVID-19, Infarction, Kidney diseases, Lupus coagulation inhibitor, Thrombosis/thromboembolism

Author Information X